Introduction {#Sec1}
============

Critical care patients frequently require emergency tracheal intubation, which usually involves preoxygenation, rapid-sequence induction, and subsequent intubation without intervening mask ventilation \[[@CR1], [@CR2]\]. Although adequate preoxygenation theoretically increases oxygen reserves by approximately 2.5-fold before preoxygenation \[[@CR3]\], the duration of apnea tolerance is shortened when oxygen storage is low because of decreased functional residual capacity (FRC), low alveolar fraction of oxygen, and/or high oxygen consumption (VO~2~) \[[@CR3]\].

Previous studies have demonstrated that, compared with the supine position, the 20°--25° head-up position improves preoxygenation and prolongs the apneic desaturation time, even in nonobese patients \[[@CR4]--[@CR7]\], because the head-up position increases the FRC \[[@CR3], [@CR8]\]. After preoxygenation, however, patients may be returned to the supine position because it is most familiar to anesthesiologists for tracheal intubation although this position change may negate the increased FRC benefits \[[@CR8]\] and shorten the apneic desaturation time \[[@CR9]\].

Patients requiring emergency tracheal intubation frequently suffer from major bleeding and/or hypovolemia. The head-down position is advantageous for increasing the preload despite decreasing the FRC, whereas the head-up position decreases preload despite high oxygen storage and might decrease cerebral tissue oxygenation \[[@CR10]\]. The efficacy of positioning for maintaining oxygenation after preoxygenation has not been examined during hypovolemia or when using cerebral oxygenation. In fact, pulse oximetry oxyhemoglobin saturation (SpO~2~) does not reflect changes in cerebral oxygenation and so could not be used to evaluate apnea tolerance in the cerebrum \[[@CR11]--[@CR13]\].

We conducted the present study to investigate the effect of four positions (supine, head-up, head-down, repositioning from head-up to supine after preoxygenation) on the time until SpO~2~ reaches \< 70% and cerebral tissue oxygenation using near-infrared spectroscopy (NIRS) under normovolemic and hypovolemic conditions in a pig model.

We hypothesized that (1) the head-up position prolongs the time to oxygen desaturation, but repositioning from the head-up to supine position after preoxygenation completely negates the benefits of the head-up position, and (2) the head-up position during hypovolemia is harmful because cerebral oxygenation decreases regardless of high oxygen storage, which is not detected by conventional pulse oximetry.

Methods {#Sec2}
=======

Animal preparation {#Sec3}
------------------

The Ethics Committee of the Animal Research Division at Hamamatsu University School of Medicine approved this study (Approval Number 2019001; provided on 15 February 2019). This study was performed in accordance with the International Association of Veterinary Editors' Consensus Author Guidelines on Animal Ethics and Welfare.

Six pigs (body weight: range 24.6--26.3 kg, mean ± SD 25.3 ± 0.6 kg) were included in this study. General anesthesia was induced by isoflurane inhalation (5%) in oxygen at 3 L/min using a standard animal face mask with each pig in the supine position. After tracheostomy with regional anesthesia, anesthesia was maintained with 2.5% inhaled isoflurane and a 1:1 L/min oxygen--air mixture \[fraction of inspired oxygen (FiO~2~) of 0.6\] via mechanical ventilation. We did not use positive end-expiratory pressure in this study. End-tidal partial pressure of carbon dioxide was set at 40--45 mmHg during animal preparation, and this ventilator setting was maintained throughout the study. A lead II electrocardiogram was monitored with three cutaneous electrodes, and pulse oximetry was monitored with a sensor (LNCS sensor; Masimo, Tokyo, Japan) positioned on the shaved left ear. The right jugular vein was cannulated with a 14-gauge double-lumen catheter and a 5-F pulmonary arterial catheter (Nihon Kohden, Tokyo, Japan), and the right femoral artery was cannulated with a 16-gauge catheter. All catheters were placed under local anesthesia after inducing general anesthesia. We infused saline 100 mL/h for maintenance intravenous fluids during the study. Body temperature was maintained throughout the study with an electric heater and air conditioning.

After these preparation steps, the parietal scalp was widely removed to avoid contamination by extracranial blood \[[@CR14]--[@CR17]\], and a NIRO^®^ probe (NIRO-200; Hamamatsu Photonics, Hamamatsu, Japan) was placed on the center of the parietal skull (bone thickness in this region is 5 mm, and the sagittal sinus is 2--3 mm for a 25-kg pig, based on computed tomography and dissection in our pilot studies). The probe, which consists of the emitter and receiver, is fixed in a rubber holder to ensure an emitter--receiver distance of 30 mm. Hence, we measured the oxygenation of the cerebrum at an approximately 20 (≈ 30 × 0.7) mm depth from the skull. Tissue oxygenation indices (TOIs) were monitored at 1-s intervals using spatially resolved spectroscopy. Details of the NIRO-200 have been explained previously \[[@CR18]--[@CR20]\].

Experimental protocol {#Sec4}
---------------------

Following animal preparation in the supine position, the 1:1 L/min inspiratory oxygen--air mixture (FiO~2~ 0.6) was changed to 100% oxygen at 2 L/min (FiO~2~ 1.0) for 5 min (preoxygenation). Four minutes after changing the fraction of inspired oxygen, 20 mg of rocuronium bromide was administered to prevent spontaneous breathing. After 5 min of preoxygenation, apnea was induced by disconnecting the pigs from the ventilator. The time until SpO~2~ reached \< 70% was then measured (primary endpoint). After meeting this criterion, mechanical ventilation with 100% oxygen was restarted for 5 min, after which the inspiratory gas mixture was returned to the baseline oxygen--air mixture of 1:1 L/min.

After the apnea experiment in the supine position, subsequent pig positions were changed to each of three positions, in the following order: (1) 20° head-up position (head-up); (2) 20° head-down position (head-down); (3) 20° head-up during preoxygenation, with immediate repositioning to supine just before disconnecting from the ventilator (head-up to supine). The three positions' order was randomly assigned to one of six patterns by drawing lots, and then the next pig was randomly assigned to one of the remaining patterns. Thus, six pigs were included in this study. After each apnea experiment, we returned each pig to the supine position for 5 min and then changed to the next position for 20 min. We did not provide for any recruitment maneuvers in the lungs during experiments. After the pig's hemodynamic parameters and cerebral tissue oxygenation stabilized, preoxygenation was restarted, and the apnea experiment was performed in each position as described above.

To induce the hypovolemic condition, we removed 600 mL of blood (approximately 33% of the pig's estimated total blood volume) via an arterial catheter. After the pig's hemodynamic parameters stabilized, 5 min of preoxygenation was initiated, and the apnea experiment was performed again and repeated in each position as described previously. The order of the body position was matched to the order during the normovolemic condition in each animal.

Heart rate (HR), mean arterial pressure (MAP), and cerebral tissue oxygenation index (TOI) were recorded, and arterial blood gases were measured before and after preoxygenation, at 30 and 60 s after the start of apnea, and at SpO~2~ \< 70%. Cardiac output (CO), hematocrit, and mixed venous blood gases were measured before preoxygenation. CO was determined via thermodilution (Cardiac Output Computer, MTC6210; Nihon Kohden) using 5 mL of cold 5% glucose injected into the right atrium. Arterial oxygen content (CaO~2~), mixed venous oxygen content (CvO~2~), oxygen delivery (DO~2~), and VO~2~ before apnea were then calculated.

Statistical analysis {#Sec5}
--------------------

Data are expressed as mean ± SD. Statistical analysis was performed using StatView 5.0 for Windows (Abacus Concepts, Berkeley, CA, USA). HR, MAP, CO, arterial carbon dioxide partial pressure (PaCO~2~), arterial oxygen partial pressure (PaO~2~), hematocrit, CaO~2~, CvO~2~, DO~2~, and VO~2~ before apnea for each position were analyzed by repeated-measures one-way analysis of variance (ANOVA). HR, MAP, PaCO~2~, PaO~2~, arterial hemoglobin oxygen saturation (SaO~2~), and cerebral TOI for each time point during apnea and for each position at the same time point were analyzed by repeated-measures ANOVA. The apneic desaturation time for each position was also analyzed by repeated-measures one-way ANOVA. If the ANOVA results were significant, we used the Scheffe F-test for multiple comparisons. Each variable during normovolemia was compared with that during hypovolemia via a paired *t* test. P values and/or 95% confidence intervals (CIs) were reported. A value of P \< 0.05 was considered to indicate statistical significance.

Results {#Sec6}
=======

Mean values for hemodynamic, blood gases, and metabolic variables before apnea in each position are shown in Table [1](#Tab1){ref-type="table"}. PaO~2~ levels before apnea were higher in both head-up and head-up to supine positions than in the supine position but did not differ significantly after 5 min of preoxygenation with 100% oxygen. Hypovolemia increased the HR and decreased MAP, CO, CvO~2~, and DO~2~. The HR, MAP, PaCO~2~, and PaO~2~ during the apnea experiments in each position are shown in Table [2](#Tab2){ref-type="table"}. Preoxygenation with 100% oxygen increased PaO~2~, and apnea decreased PaO~2~ and increased PaCO~2~. In both normovolemia and hypovolemia, PaO~2~ during apnea after 30 s was higher in the head-up position than in the supine position, and PaO~2~ during apnea after 60 s was higher in the head-up position than in all other positions.Table 1Hemodynamic, blood gas and metabolic variables before apnea (FiO~2~ = 0.6) in each positionSupineHead-upHead-downHead-up to supineNormovolemia (n = 6) HR (beats/min)123 ± 27144 ± 34130 ± 24140 ± 32 MAP (mmHg)74 ± 866 ± 669 ± 968 ± 7 CO (L/min)2.8 ± 0.52.4 ± 0.33.0 ± 0.62.3 ± 0.3 PaCO~2~ (mmHg)45 ± 445 ± 846 ± 743 ± 5 PaO~2~ (mmHg)152 ± 35190 ± 30\*173 ± 20191 ± 34\* PaO~2\ F1.0~ (mmHg)255 ± 64309 ± 52289 ± 36306 ± 62 Hematocrit (%)31 ± 433 ± 432 ± 432 ± 3 CaO~2~ (mL/dL)13.9 ± 2.015.0 ± 1.714.3 ± 1.614.5 ± 1.2 CvO~2~ (mL/dL)9.4 ± 1.49.1 ± 1.09.5 ± 1.58.4 ± 1.3 DO~2~ (mL/min)386 ± 77360 ± 56436 ± 116338 ± 64 VO~2~ (mL/min)122 ± 21143 ± 30144 ± 44141 ± 29Hypovolemia (n = 6) HR (beats/min)199 ± 41^¶^215 ± 35^¶^198 ± 37^¶^210 ± 37^¶^ MAP (mmHg)52 ± 9^¶^45 ± 11^¶^53 ± 1342 ± 8^¶^ CO (L/min)1.6 ± 0.1^¶^1.4 ± 0.2^¶^2.1 ± 0.3^\#¶^1.3 ± 0.2^¶^ PaCO~2~ (mmHg)42 ± 3^¶^39 ± 644 ± 139 ± 5^¶^ PaO~2~ (mmHg)152 ± 35179 ± 31158 ± 11153 ± 38 PaO~2\ F1.0~ (mmHg)239 ± 69305 ± 60\*265 ± 17263 ± 61 Hematocrit (%)29 ± 329 ± 528 ± 528 ± 3^¶^ CaO~2~ (mL/dL)13.0 ± 1.313.0 ± 2.112.9 ± 2.112.8 ± 1.4^¶^ CvO~2~ (mL/dL)5.4 ± 2.0^¶^4.1 ± 1.1^¶^6.1 ± 1.8^†¶^3.9 ± 1.5^‡¶^ DO~2~ (mL/min)210 ± 32^¶^188 ± 54^¶^267 ± 55^†¶^172 ± 40^‡¶^ VO~2~ (mL/min)121 ± 17129 ± 45140 ± 16117 ± 21Data are expressed as mean values ± SD*HR* heart rate, *MAP* mean arterial pressure, *CO* cardiac output, *PaO*~*2**F1.0*~ PaO~2~ after ventilated by 100% oxygen for 5 min, *CaO*~*2*~ arterial oxygen content, *CvO*~*2*~ mixed venous oxygen content, *DO*~*2*~ oxygen delivery, VO~2~ oxygen consumption\*Significant difference versus supine position^†^Significant difference versus head-up position^‡^Significant difference versus head-down position^\#^Significant difference vs. all other conditions^¶^Significant difference versus during normovolemiaTable 2Heart rate (HR), mean arterial pressure (MAP), partial pressure of arterial carbon dioxide (PaCO~2~) and oxygen (PaO~2~) before and during apnea in each positionFiO~2~ 0.6FiO~2~ 1.0Apnea 30 sApnea 60 sSpO~2~ \< 70%Normovolemia (n = 6) HR (beats/min)  Supine123 ± 27117 ± 24112 ± 21\*111 ± 21\*116 ± 22  Head-up144 ± 34136 ± 38130 ± 36129 ± 35142 ± 33^ǀ^  Head-down130 ± 24127 ± 27122 ± 26124 ± 27133 ± 27^‡^  Head-up to supine140 ± 32133 ± 30125 ± 31\*125 ± 29\*133 ± 26 MAP (mmHg)  Supine74 ± 870 ± 968 ± 669 ± 673 ± 10  Head-up66 ± 662 ± 862 ± 767 ± 986 ± 9^\#^  Head-down69 ± 968 ± 1066 ± 1070 ± 1080 ± 10^\#^  Head-up to supine68 ± 762 ± 867 ± 874 ± 10^†^81 ± 12\*^†‡^ PaCO~2~ (mmHg)  Supine45 ± 444 ± 458 ± 4^\#^64 ± 4^\#^70 ± 4^\#^  Head-up45 ± 844 ± 759 ± 9^\#^65 ± 8^\#^73 ± 9^\#^  Head-down46 ± 745 ± 758 ± 6^\#^64 ± 7^\#^68 ± 8^\#ǁ^  Head-up to supine43 ± 543 ± 659 ± 6^\#^64 ± 7^\#^70 ± 7^\#^ PaO~2~ (mmHg)  Supine152 ± 35255 ± 64\*177 ± 54^†^87 ± 20^†‡^42 ± 2\*^†‡^  Head-up190 ± 30^ǀ^309 ± 52\*250 ± 41\*^†ǀ^125 ± 31\*^†‡§^44 ± 2^\#^  Head-down173 ± 20289 ± 36\*197 ± 53^†^84 ± 19\*^†‡^43 ± 3\*^†‡^  Head-up to supine191 ± 34^ǀ^306 ± 62\*177 ± 37^†ǁ^78 ± 16\*^†‡^42 ± 2\*^†‡^Hypovolemia (n = 6) HR (beats/min)  Supine199 ± 41197 ± 40186 ± 36\*187 ± 37\*193 ± 38  Head-up215 ± 35218 ± 36201 ± 34190 ± 34\*^†^197 ± 29^†^  Head-down198 ± 37200 ± 42185 ± 42177 ± 37^†^179 ± 34  Head-up to supine210 ± 37207 ± 35189 ± 35\*181 ± 34\*^†^183 ± 30\*^†^ MAP (mmHg)  Supine52 ± 950 ± 844 ± 652 ± 1164 ± 18^†‡^  Head-up45 ± 1143 ± 1340 ± 1240 ± 1059 ± 23  Head-down53 ± 1349 ± 1043 ± 744 ± 949 ± 15  Head-up to supine42 ± 838 ± 1341 ± 1642 ± 1650 ± 20 PaCO~2~ (mmHg)  Supine42 ± 343 ± 362 ± 2^\#^69 ± 2^\#^76 ± 5^\#^  Head-up39 ± 639 ± 657 ± 8^\#^66 ± 7^\#^75 ± 8^\#^  Head-down44 ± 143 ± 261 ± 3^\#^66 ± 3^\#^70 ± 3^\#^  Head-up to supine39 ± 539 ± 562 ± 5^\#^67 ± 5^\#^74 ± 6^\#^ PaO~2~ (mmHg)  Supine152 ± 35239 ± 69\*172 ± 683 ± 24^†‡^44 ± 4\*^†‡^  Head-up179 ± 31305 ± 60\*^ǀ^249 ± 43\*^†ǀ^116 ± 16\*^†‡§^48 ± 5^\#^  Head-down158 ± 11265 ± 17\*206 ± 20\*^†^79 ± 10\*^†‡^48 ± 9^\#^  Head-up to supine153 ± 38263 ± 61\*211 ± 4586 ± 16\*^†‡^48 ± 4\*^†‡^Data are expressed as mean values ± SD\*Significant difference versus FiO~2~ 0.6^†^Significant difference versus FiO~2~ 1.0^‡^Significant difference versus Apnea 30 s^\#^Significant difference versus all other time points^ǀ^Significant difference versus supine position at same time point^ǁ^Significant difference versus head-up position at same time point^§^Significant difference versus all other positions at same time point

The SpO~2~ \< 70% time (seconds) in each position during normovolemia was 108 ± 13 (supine), 138 ± 15 (head-up), 101 ± 12 (head-down), and 106 ± 15 (head-up to supine) (Fig. [1](#Fig1){ref-type="fig"}). The mean (95% CI) differences for SpO~2~ \< 70% time between the head-up position and the supine, head-down, or head-up to supine positions, were 29 (21 to 38), P \< 0.0001; 37 (28 to 46), P \< 0.0001; and 32 (26 to 38), P \< 0.0001, respectively. The head-up position during normovolemia significantly prolonged the time to SpO~2~ \< 70% compared with the other positions. During hypovolemia, the SpO~2~ \< 70% times (seconds) were 110 ± 29 (supine), 120 ± 7 (head-up), 101 ± 16 (head-down), and 106 ± 11 (head-up to supine). The mean (95% CI) differences in the time to SpO~2~ \< 70% between the head-up position and each other position were 11 (− 11 to 33), P = 0.60; 19 (10 to 28), P = 0.16; and 15 (4 to 25), P = 0.36, respectively. The time to SpO~2~ \< 70% in the head-up position decreased significantly during hypovolemia (P = 0.02), and hypovolemia decreased the effect of the head-up position on prolonging the time to desaturation.Fig. 1Apneic desaturation time (time to pulse oximetry hemoglobin saturation (SpO~2~) \< 70%) in each position. ^\#^Significant difference versus all other positions during normovolemia (P = 0.015 versus supine; P = 0.002 versus head-down; P = 0.008 versus head-up to supine). \*Significant difference (P = 0.017) between normovolemia and hypovolemia in the head-up position

Changes in SaO~2~ during apnea are shown in Fig. [2](#Fig2){ref-type="fig"}. During normovolemia, SaO~2~ at FiO~2~ 0.6 were 100 ± 0 (supine), 100 ± 0 (head-up), 100 ± 0 (head-down), and 100 ± 0 (head-up to supine) (P = 0.99); 100 ± 0, 100 ± 0, 100 ± 0, and 100 ± 0 at FiO~2~ 1.0 (P = 0.99); 99 ± 1, 100 ± 0, 99 ± 1, and 100 ± 0 at apnea 30 s (P = 0.31); 92 ± 7, 98 ± 2, 91 ± 8, and 90 ± 6 at apnea 60 s (P = 0.0016); and 56 ± 3, 59 ± 3, 59 ± 3, and 56 ± 2 at SpO~2~ \< 70% (P = 0.19), respectively. SaO~2~ at apnea 60 s in the head-up was significantly higher than those in all other positions. During hypovolemia, SaO~2~ at FiO~2~ 0.6 were 100 ± 0 (supine), 100 ± 0 (head-up), 100 ± 0 (head-down), and 100 ± 0 (head-up to supine) (P = 0.99); 100 ± 0, 100 ± 0, 100 ± 0, and 100 ± 0 at FiO~2~ 1.0 (P = 0.99); 100 ± 0, 100 ± 0, 100 ± 0, and 100 ± 0 at apnea 30 s (P = 0.99); 89 ± 9, 98 ± 2, 90 ± 4, and 92 ± 4 at apnea 60 s (P = 0.03); and 57 ± 4, 63 ± 7, 61 ± 7, and 58 ± 3 at SpO~2~ \< 70% (P = 0.23), respectively. SaO~2~ at apnea 60 s in the head-up position was significantly higher than that in the supine position. Each SaO~2~ at each time point in each position did not significantly change after hypovolemia.Fig. 2Changes in arterial hemoglobin oxygen saturation (SaO~2~) during the apnea experiments in each position during normovolemia (**a**) and hypovolemia (**b**). FiO~2~ 0.6 = fraction of inspired oxygen of 0.6 (before preoxygenation); FiO~2~ 1.0 = fraction of inspired oxygen of 1.0 (before starting apnea); Apnea 30 s = 30 s after the start of apnea; Apnea 60 s = 60 s after the start of apnea; SpO~2~ \< 70% = SpO~2~ reaching a value of less than 70%. \*Significant difference vs. FiO~2~ 0.6 in each position \[supine: P = 0.0082 and P = 0.0094 (normovolemia and hypovolemia); head-down: P = 0.0043 and P = 0.0017; head-up to supine: P \< 0.0001 and P = 0.0001\]. ^†^Significant difference vs. FiO~2~ 1.0 in each position \[supine: P = 0.0050 and P = 0.0070 (normovolemia and hypovolemia); head-down: P = 0.0035 and P = 0.0015; head-up to supine: P \< 0.0001 and P \< 0.0001\]. ^‡^Significant difference vs. apnea 30 s in each position \[supine: P = 0.0097 and P = 0.0076 (normovolemia and hypovolemia); head-down: P = 0.0062 and P = 0.0016; head-up to supine: P \< 0.0001 and P \< 0.0001\]. ^\#^Significant difference vs. all other time points (P \< 0.0001 vs. each time point in all positions in both normovolemia and hypovolemia). ^ǀ^Significant difference vs. supine position at apnea 60 s (P = 0.0459). ^§^Significant difference vs. supine, head-down, and head-up to supine at apnea 60 s (P = 0.035, P = 0.0096, and P = 0.0039)

Changes in cerebral TOI during apnea are shown in Fig. [3](#Fig3){ref-type="fig"}. During normovolemia, cerebral TOIs at FiO~2~ 0.6 were 68 ± 3 (supine), 68 ± 6 (head-up), 69 ± 6 (head-down), and 68 ± 6 (head-up to supine) (P = 0.87); 71 ± 4, 68 ± 6, 70 ± 6, and 69 ± 6 at FiO~2~ 1.0 (P = 0.37); 71 ± 5, 69 ± 5, 70 ± 7, and 70 ± 6 at apnea 30 s (P = 0.64); 67 ± 6, 69 ± 7, 65 ± 7, and 67 ± 7 at apnea 60 s (P = 0.08); and 52 ± 6, 56 ± 9, 54 ± 8, and 56 ± 8 at SpO~2~ \< 70% (P = 0.43), respectively. There were no significant differences in TOI values among the positions during normovolemia. In contrast, during hypovolemia, cerebral TOIs at FiO~2~ 0.6 were 62 ± 6 (supine), 50 ± 9 (head-up), 61 ± 4 (head-down), and 50 ± 6 (head-up to supine) (P = 0.0019); 62 ± 7, 50 ± 10, 61 ± 5, and 49 ± 10 at FiO~2~ 1.0 (P = 0.0020); 59 ± 10, 49 ± 11, 60 ± 7, and 50 ± 10 at apnea 30 s (P = 0.0196); 58 ± 10, 49 ± 10, 56 ± 6, and 49 ± 10 at apnea 60 s (P = 0.0606); and 47 ± 12, 43 ± 7, 47 ± 7, and 43 ± 8 at SpO~2~ \< 70% (P = 0.4632), respectively. During hypovolemia, cerebral TOI before apnea (FiO~2~ 0.6 and FiO~2~ 1.0) in the head-up and head-up to supine positions were significantly lower than those in the supine and head-down positions, an effect that tended to continue until reaching SpO~2~ \< 70%. Each TOI at each time point in each position decreased after hypovolemia except TOIs at apnea 60 s and at SpO~2~ \< 70% in the supine and head-down positions.Fig. 3Changes in the cerebral tissue oxygenation index (TOI) during the apnea experiments in each position during normovolemia (**a**) and hypovolemia (**b**). FiO~2~ 0.6 = fraction of inspired oxygen of 0.6 (before preoxygenation); FiO~2~ 1.0 = fraction of inspired oxygen of 1.0 s (before starting apnea); Apnea 30 s = 30 s after the start of apnea; Apnea 60 s = 60 s after the start of apnea; SpO~2~ \< 70% = SpO~2~ reaching a value of \< 70%. \*Significant difference vs. FiO~2~ 0.6 in each position (head-down during normovolemia: P = 0.0043; head-up to supine during normovolemia and hypovolemia: P = 0.0489 and P = 0.0150). ^†^Significant difference vs. FiO~2~ 1.0 in each position (head-down during normovolemia and hypovolemia: P = 0.0093 and P = 0.0303; head-up to supine during normovolemia: P = 0.0319). ^‡^Significant difference vs. apnea 30 s in each position (head-down during normovolemia: P = 0.0093; head-up to supine during normovolemia and hypovolemia: P = 0.0222 and P = 0.0126). ^\#^Significant difference vs. all other time points (supine during normovolemia: P = 0.0005, P \< 0.0001, P \< 0.0001, and P = 0.0010 vs. FiO~2~ 0.6, FiO~2~ 1.0, apnea 30 s, and apnea 60 s; head-up during normovolemia: P = 0.0453, P = 0.00494, P = 0.0346, and P = 0.0316; supine during hypovolemia: P \< 0.0001, P \< 0.0001, P \< 0.0001, and P = 0.0003; head-up during hypovolemia: P = 0.0001, P = 0.0003, P = 0.0008, and P = 0.0024; head-down during hypovolemia: P \< 0.0001 vs. all time points). ^¶^Significant difference vs. supine and head-down positions (head-up: P = 0.0202 and P = 0.0360 at FiO~2~ 0.6, and P = 0.0305, and P = 0.0395 at FiO~2~ 1.0; head-up to supine: P = 0.0202 and 0.0360 at FiO~2~ 0.6 and P = 0.0198 and P = 0.0257 at FiO~2~ 1.0)

The relations between cerebral TOI and SaO~2~ in each position during apnea are shown in Fig. [4](#Fig4){ref-type="fig"}. During normovolemia, the relations were comparable between positions. However, during hypovolemia, these relations shifted to the left in all positions, especially in the head-up and head-up to supine positions, during which we saw dramatic shifts to the left and decreased TOIs at similar SaO~2~ levels.Fig. 4Relations between cerebral tissue oxygenation index (TOI) and arterial hemoglobin oxygen saturation (SaO~2~) in each position during normovolemia (**a**) and hypovolemia (**b**). The lines denote the following: after preoxygenation (FiO~2~ 1.0), 30 s after apnea (Apnea 30 s), 60 s after apnea (Apnea 60 s), and SpO~2~ \< 70%. We omitted the error bars and significance indicators because this information is shown in Figs. [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}
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Our results showed that the increased time to SpO~2~ \< 70% seen in the head-up position was completely reversed by repositioning to supine just before disconnecting the pigs from oxygen. The time also decreased during hypovolemia. In addition, the head-up position decreased cerebral oxygenation considerably during hypovolemia---in contrast to normovolemia in which cerebral oxygenation was not associated with the pigs' positions.

We saw the longest time to SpO~2~ \< 70% in the head-up position during normovolemia, similar to the results of previous reports \[[@CR4]--[@CR7]\]. However, few studies have investigated the effect of repositioning to supine regarding the benefits of head-up preoxygenation \[[@CR9]\]. Khandelwal et al. investigated the association between the intubation position and emergent tracheal intubation-related complications. They found that the back-up head-elevated position reduced airway-related complications \[[@CR21]\]. Lee et al. reported that the 25° back-up position provided a better laryngeal view than the supine position \[[@CR22]\]. Although these findings suggested that the head-up position is more suitable for tracheal intubation than the supine position, anesthesiologists are accustomed to the supine position and may change patients to that position after head-up preoxygenation \[[@CR6]\].

Adequate preoxygenation increases oxygen reserves in alveolar, arterial, venous, and tissue compartments. During normovolemia in our study, CaO~2~, CvO~2~, and DO~2~ did not differ among positions, suggesting that oxygen reserves in the blood and tissue compartments were comparable in all positions. Therefore, the pulmonary reserve in the FRC, which varies with body position, affected the time to SpO~2~ \< 70%. The increased FRC that we saw during the head-up position quickly disappeared by repositioning to supine, which completely negated the prolonged time to SpO~2~ \< 70% obtained in the head-up position.

Although PaO~2~ at apnea 60 s was higher in the head-up position than in all other positions during hypovolemia (Table [2](#Tab2){ref-type="table"}) and SaO~2~ at apnea 60 s in the head-up position was also higher than that in the supine position (Fig. [2](#Fig2){ref-type="fig"}), it is unclear that hypovolemia decreased the effect of the head-up position on the time to desaturation. The head-up position worsened hemodynamics during hypovolemia and decreased DO~2~, although VO~2~ did not change. We speculate that the head-up position during hypovolemia increased the ventilation/perfusion ratio secondary to low perfusion (dead space-like effect) and, compared with normovolemia, decreased the alveolar fraction of oxygen, resulting in decreased oxygen storage after preoxygenation despite seeing no change in the increased FRC \[[@CR3]\].

Several previous studies reporting the benefits of head-up preoxygenation evaluated only the time to desaturation and/or PaO~2~ after preoxygenation, without investigating changes in cerebral oxygenation \[[@CR4]--[@CR7]\]. Others, however, indicated that the head-up position, even during normovolemia, decreased cerebral oxygenation in animals \[[@CR10]\] and healthy adult humans \[[@CR23]\]. The present study has uniquely evaluated the benefits of head-up preoxygenation during normal and hypovolemic conditions using both pulse oximetry and NIRS. Furthermore, in our study, the parietal scalp was removed to exclude contamination of scalp blood flow \[[@CR14]--[@CR17]\], which is a limitation of NIRS. This maneuver allowed us to provide accurate cerebral oxygenation values using NIRS. If the present study had evaluated only the time to desaturation and/or PaO~2~ after preoxygenation, similar to previous studies, the demerit of the head-up position during hypovolemia could not be identified.

During normovolemia, the relations between TOI and SaO~2~ were comparable among the positions (Fig. [4](#Fig4){ref-type="fig"}a). During hypovolemia, however, each TOI significantly decreased and, especially in the head-up and head-up to supine positions, shifted the relation to the left at similar SaO~2~ levels (Fig. [4](#Fig4){ref-type="fig"}b). Specifically, TOI values in the head-up and head-up to supine positions during hypovolemia were approximately 50% at 100% of SaO~2~, which were similar to the TOI values in the supine and head-down positions at \< 70% of SaO~2~. This deterioration in cerebral oxygenation could not be identified by SaO~2~ (Fig. [2](#Fig2){ref-type="fig"}b) and/or SpO~2~ values. TOI did not recover even when the head-up position was changed to supine just before apnea. Caregivers should consider that the head-up position during hypovolemia can reduce cerebral oxygenation. We previously showed that acute anemia (hemorrhage and subsequent fluid resuscitation) and/or β1-blocker administration also shifted the relation between TOI and SaO~2~ to the left, and reduced cerebral tolerance for hypoxia \[[@CR12]\]. The effect is substantially enhanced by β1-blocker administration during acute anemia, and this phenomenon is thought to partly explain why β-blockers can increase the incidence of stroke under acute hemodilution during the perioperative period. In contrast, dobutamine, a β1-stimulant, increased cerebral tolerance for hypoxia and/or anemia \[[@CR13]\]. These alterations of cerebral tolerance could not be identified with arterial blood oxygenation. On the basis of these findings, we recommend NIRS monitoring at 1-s intervals along with pulse oximetry for emergent tracheal intubation in critical care patients. Cerebral NIRS, which estimates the oxygen supply/demand balance, might predict individual apneic tolerance better than the desaturation time.

Several limitations of this study must be noted. First, we used the apneic desaturation time in the first supine position as a reference for comparisons with results in the other positions, whereas interpreting the data may have been more reliable if we had included a time control group with no changes in the pigs' position. Furthermore, we induced apnea by disconnecting them from the ventilator after 5 min of 100% oxygen ventilation. This state, however, might not represent clinical preoxygenation, which typically includes the non-ventilated, but oxygen-diffusion, duration via face mask. In addition, the time to SpO~2~ \< 70% after 100% oxygen preoxygenation for 5 min was only 100--140 s in our animals, which is shorter than the expected time in adult humans \[[@CR24]\]. The VO~2~ of the pigs in our study, which were approximately 2 months old, was approximately 170 mL/min/m^2^ at baseline before apnea occurred (the pigs' mean body surface area was 0.77 m^2^, calculated by body weight \[[@CR25]\]), which is equivalent to the VO~2~ of a human infant. Although the size of the oxygen reservoir in the lungs and/or FRC might be small in pigs, high VO~2~ is likely to be the main reason for the early decrease in SpO~2~. Therefore, our findings should not be directly extrapolated to adult human patients. Finally, although changes in time to SpO~2~ \< 70% and/or TOI secondary to the position changes were evident, and the order of the pigs' positions was randomized, the number of study animals was small. Larger, human studies are needed to clarify our findings.

In conclusion, the head-up position improves preoxygenation and should not be changed to supine after preoxygenation. The head-up position should be retained during tracheal intubation. Although the effects of postural changes on cerebral oxygenation are minimal under normal circulatory volume, under evident hypovolemia the head-up position can decrease cerebral oxygenation, which is not detected by conventional pulse oximetry. Thus, head-up preoxygenation might be harmful in these patients.
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